Skip to Navigation

Stem Cell Research


The American Diabetes Association supports the use of stem cell research in biomedical research, provided such use is consistent with federal guidelines relating to the bioethics for their use. Scientists from across the United States and throughout the world – including those at ADA – believe that stem cell research, especially embryonic stem cell research, holds great promise in the search for a cure and better treatments for diabetes.

Stem cell research allows scientists to better explore how to control and direct stem cells so they can grow into other cells, such as insulin-producing beta cells found in the pancreas. Creating new beta cells could mean a cure for type 1 diabetes as they would serve as a replenishing source of cells for islet cell transplantation. They could also provide a powerful tool for controlling type 2 diabetes.

The Association strongly supports H.R.3/S.5, the "Stem Cell Research Enhancement Act," which would expand federal funding for embryonic stem cell research, while keeping President Bush's ethical framework from his 2001 policy. In the last session of Congress, both the House of Representatives and Senate passed the bill with bipartisan support, but were unable to override President Bush's veto.

Fortunately, the bill has been reintroduced and it has already passed the U.S. House of Representatives. The Senate is currently considering this bill and a vote is expected during the week of April 9. ADA will continue to fight to expand the federal commitment to stem cell research.



Stem Cell Resourcs

Press Releases

Other Resources

Web Links

 

Diabetes Forecast - FREE ISSUE!

Advocacy Action Center

New Medicare Update

Meet Tesch West - National Youth Advocate

School Walk for Diabetes

Commercial Drivers with diabetes

Get involved in your local community.